메뉴 건너뛰기




Volumn 17, Issue 7, 2000, Pages 543-545

Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1α gene mutations: Evidence for pharmacogenetics in diabetes

Author keywords

Genetics; HNF 1 ; MODY; Pharmacogenetics; Sulphonylurea sensitivity

Indexed keywords

CHLORPROPAMIDE; FRUCTOSAMINE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; METFORMIN; NUCLEAR FACTOR I; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE;

EID: 0033847575     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00305.x     Document Type: Article
Times cited : (246)

References (9)
  • 1
    • 0031914679 scopus 로고    scopus 로고
    • Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
    • (1998) Diabet Med , vol.15 , pp. 15-24
    • Hattersley, A.T.1
  • 7
    • 0021857942 scopus 로고
    • UKPDS. II. Reduction in HbA(1c) with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study
    • (1985) Diabetes , vol.34 , pp. 793-798


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.